Substituting BCNU by thiotepa in the conditioning regimen of patients with lymphomas undergoing an autologous stem cell transplantation (team protocol). The experience of one centre

被引：0
|
作者：
Maw, D. [1 ]
Jansen, A. [1 ]
Sims, H. [1 ]
Crawley, C. [1 ]
Sureda, A. [1 ]
机构：
[1] Addenbrookes Hosp, Cambridge, England
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S449 / S449
页数：1
相关论文
共 50 条
  • [21] Risk and benefit of thiotepa based conditioning followed by autologous stem cell transplantation in high risk lymphomas
    Csukly, Zoltan
    Gopcsa, Laszlo
    Barta, Aniko
    Paksi, Melinda
    Sari, Eszter
    Reti, Mariann
    Remenyi, Peter
    BONE MARROW TRANSPLANTATION, 2019, 54 : 225 - 226
  • [22] Thiotepa, Etoposide, Cyclophosphamide, Cytarabine, and Melphalan (TECAM) Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma
    Grisariu, Sigal
    Shapira, Michael Y.
    Or, Reuven
    Avni, Batia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (04): : 272 - 279
  • [23] Treosulfan and Fludarabine based Conditioning regimen in Pediatric Patients undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A single centre experience
    Foell, J.
    Buerle, K.
    Dannenmaier, A-K.
    Jakob, M.
    Rebe, K.
    Corbacioglu, S.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5591 - 5591
  • [24] Modified BEAM as a conditioning regimen for mantle cell lymphoma patients undergoing autologous hematopoietic stem cell transplantation
    Galieni, Piero
    Falcioni, Sadia
    Troiani, Emanuela
    Picardi, Paola
    Bigazzi, Catia
    Maravalle, Denise
    De Giorgi, Federica
    Taborro, Roberta
    Angelini, Stefano
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2024, 15
  • [25] Thiotepa 10 mg/kg seems superior to Thiotepa 5 mg/kg in the TBF conditioning regimen in patients undergoing allogeneic stem cell transplantation
    El-Cheikh, Jean
    Massoud, Radwan
    Moukalled, Nour
    Haffar, Basel
    Zahreddine, Ammar
    Mahfouz, Rami
    Bazarbachi, Ali
    BONE MARROW TRANSPLANTATION, 2018, 53 : 294 - 295
  • [26] THIOTEPA-TREOSULFAN-FLUDARABINE (TTF) AS CONDITIONING REGIMEN IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLOHSCT) FOR MYELOFIBROSIS
    Canale, Filippo Antonio
    Porto, Gaetana
    Verduci, Chiara
    Celentano, Maria
    Loteta, Barbara
    Pugliese, Marta
    Naso, Virginia
    Moscato, Tiziana
    Irrera, Giuseppe
    Console, Giuseppe
    Ferreri, Anna
    Picardi, Alessandra
    Martino, Massimo
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 496 - 497
  • [27] Bucye Can Safely Replace BEAM As Conditioning Regimen for Autologous Stem Cell Transplantation for Relapsed Lymphomas
    Sapelli, Jaqueline
    Schmidt Filho, Jayr
    Matias Vieira, Garles Miller
    Moura, Fernanda Lemos
    Germano, Janaina Naiara
    Cordeiro de Lima, Vladmir Claudio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S152 - S152
  • [28] Excellent Outcomes in Patients with Primary and Secondary Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using a Rituximab, Busulfan, Melphalan, Thiotepa Conditioning Regimen
    Philip, Shona
    Fulford, Adrienne
    Lam, Selay
    Phua, Chai Wye
    Mangel, Joy
    Howson-Jan, Kang
    Dorland, Brandon
    Atkinson, Karen
    Xenocostas, Anargyros
    Deotare, Uday
    BLOOD, 2020, 136
  • [29] TOTAL BODY IRRADIATION AND THIOTEPA AS CONDITIONING TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH FOLLICULAR LYMPHOMA
    Capponi, M.
    Falzetti, F.
    Flenghi, L.
    Di Ianni, M.
    Minga, P.
    Falcinelli, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 62 - 62
  • [30] BTM: an alternative conditioning regimen for autologous stem cell transplantation
    De Rosa, G.
    Morelli, E.
    Montante, B.
    De Rosa, A.
    Rotoli, B.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S252 - S252
12345